{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T20:30:16Z","timestamp":1786480216743,"version":"build-2736575974"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Kidney360"],"published-print":{"date-parts":[[2026,5]]},"abstract":"\n Key Points<\/jats:title>\n \n \n \n The causal relationship between serum osmolality and kidney outcome remained unclear in patients with autosomal dominant polycystic kidney disease.<\/jats:p>\n <\/jats:list-item>\n \n Serum osmolality may be a possible surrogate marker for the clinical monitoring of autosomal dominant polycystic kidney disease patients, especially when access to copeptin level is limited.<\/jats:p>\n <\/jats:list-item>\n \n High serum osmolality conveys possible detrimental effect on the kidney outcomes.<\/jats:p>\n <\/jats:list-item>\n <\/jats:list>\n <\/jats:p>\n <\/jats:sec>\n \n Background<\/jats:title>\n Current treatment of autosomal dominant polycystic kidney disease (ADPKD) is mainly focused on inhibiting cystogenesis through arginine vasopressin suppression, and there has been interest in achieving similar vasopressin suppression by reduction of osmolality with increased water intake. However, the causal relationship between serum osmolality (sOSM) and kidney outcome remained unclear in patients with ADPKD. We aim to evaluate the relationship of sOSM and its effect on kidney outcome in patients with ADPKD.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n Three hundred and eleven tolvaptan treatment-na\u00efve patients with ADPKD were recruited prospectively from the CysticHK cohort, a territory-wide ADPKD registry across 12 tertiary hospitals in Hong Kong. Beside clinical data, serial measurement of serum, and urinary osmolality were obtained every 6 months over 5 years. All participants were treated according to the standard of clinical care. The primary outcome was the 40% decline from baseline eGFR.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n Patients with a high sOSM have a worse kidney outcome, as shown by the Kaplan\u2013Meier plots (log-rank\n P<\/jats:italic>\n \u2264 0.001) and the Cox regression model that showed a 5.91 times higher risk of reaching 40% eGFR decline compared with the top with bottom quartiles of osmolality (\n P<\/jats:italic>\n = 0.018). By contrast, there is an inverse relationship for urine osmolality. A receiver-operating characteristic analysis to assess the predictive efficacy of osmolality for identifying those at high risk of kidney decline also showed a good performance for sOSM (area under the curve, 0.81; 95% confidence interval, 0.73 to 0.89;\n P<\/jats:italic>\n < 0.001). The urinary osmolality did not show a clinical meaningful predictive efficacy (area under the curve, 0.35; 95% confidence interval, 0.28 to 0.43;\n P<\/jats:italic>\n = 0.003).\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n sOSM may be a possible surrogate marker for the clinical monitoring of patients with ADPKD, especially when access to copeptin level is limited; and high sOSM conveys possible detrimental effect on the kidney outcomes.<\/jats:p>\n <\/jats:sec>","DOI":"10.34067\/kid.0000001126","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T17:00:23Z","timestamp":1770915623000},"page":"1095-1103","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["The Relationship of Osmolality and Kidney Outcomes in Patients with Autosomal Dominant Polycystic Kidney Disease"],"prefix":"10.34067","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7676-7628","authenticated-orcid":false,"given":"Winston Wing-Shing","family":"Fung","sequence":"first","affiliation":[{"name":"Department of Medicine and Therapeutics, Prince of Wales Hospital, Hong Kong, Hong Kong SAR"},{"name":"CUHK Carol and Richard Yu Peritoneal Dialysis Research Centre, Hong Kong, Hong Kong SAR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8898-8505","authenticated-orcid":false,"given":"Cheuk-Chun","family":"Szeto","sequence":"additional","affiliation":[{"name":"Department of Medicine and Therapeutics, Prince of Wales Hospital, Hong Kong, Hong Kong SAR"},{"name":"CUHK Carol and Richard Yu Peritoneal Dialysis Research Centre, Hong Kong, Hong Kong SAR"},{"name":"Li Ka Shing Institute of Health Sciences (LiHS), The Chinese University of Hong Kong, Shatin, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5310-5197","authenticated-orcid":false,"given":"Kai-Ming","family":"Chow","sequence":"additional","affiliation":[{"name":"Department of Medicine and Therapeutics, Prince of Wales Hospital, Hong Kong, Hong Kong SAR"},{"name":"CUHK Carol and Richard Yu Peritoneal Dialysis Research Centre, Hong Kong, Hong Kong SAR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2276-9043","authenticated-orcid":false,"given":"Amelia Chien-Wei","family":"Chao","sequence":"additional","affiliation":[{"name":"Department of Medicine and Therapeutics, Prince of Wales Hospital, Hong Kong, Hong Kong SAR"},{"name":"CUHK Carol and Richard Yu Peritoneal Dialysis Research Centre, Hong Kong, Hong Kong SAR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0880-9998","authenticated-orcid":false,"given":"Vickie Wai-Ki","family":"Kwong","sequence":"additional","affiliation":[{"name":"Department of Medicine and Therapeutics, Prince of Wales Hospital, Hong Kong, Hong Kong SAR"},{"name":"CUHK Carol and Richard Yu Peritoneal Dialysis Research Centre, Hong Kong, Hong Kong SAR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0005-6878","authenticated-orcid":false,"given":"Sam Lik-Fung","family":"Lau","sequence":"additional","affiliation":[{"name":"Department of Medicine and Therapeutics, Prince of Wales Hospital, Hong Kong, Hong Kong SAR"},{"name":"CUHK Carol and Richard Yu Peritoneal Dialysis Research Centre, Hong Kong, Hong Kong SAR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2963-511X","authenticated-orcid":false,"given":"Wing-Fai","family":"Pang","sequence":"additional","affiliation":[{"name":"Department of Medicine and Therapeutics, Prince of Wales Hospital, Hong Kong, Hong Kong SAR"},{"name":"CUHK Carol and Richard Yu Peritoneal Dialysis Research Centre, Hong Kong, Hong Kong SAR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6625-8536","authenticated-orcid":false,"given":"Ho-Kwan","family":"Sin","sequence":"additional","affiliation":[{"name":"Department of Medicine and Geriatrics, Kwong Wah Hospital, Hong Kong, Hong Kong SAR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2476-1033","authenticated-orcid":false,"given":"Elaine","family":"Ho","sequence":"additional","affiliation":[{"name":"Department of Medicine, Tseung Kwan O Hospital, Hong Kong, Hong Kong SAR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorraine Pui-Yuen","family":"Kwan","sequence":"additional","affiliation":[{"name":"Department of Medicine, Tung Wah Hospital, Hong Kong, Hong Kong SAR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koon-Ming","family":"Chan","sequence":"additional","affiliation":[{"name":"Department of Medicine, Queen Elizabeth Hospital, Hong Kong, Hong Kong SAR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4581-4724","authenticated-orcid":false,"given":"Gary Tung-Sen","family":"Shum","sequence":"additional","affiliation":[{"name":"Department of Medicine and Geriatrics, Princess Margaret Hospital, Hong Kong, Hong Kong SAR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6391-7172","authenticated-orcid":false,"given":"Anthony Kai-Ching","family":"Hau","sequence":"additional","affiliation":[{"name":"Department of Medicine and Geriatrics, Tuen Mun Hospital, Hong Kong, Hong Kong SAR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ka-Lok","family":"Chan","sequence":"additional","affiliation":[{"name":"Department of Medicine and Geriatrics, United Christian Hospital, Hong Kong, Hong Kong SAR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald Chi-Chun","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Medicine and Geriatrics, Caritas Medical Centre, Hong Kong, Hong Kong SAR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7395-7435","authenticated-orcid":false,"given":"Lap-Ming","family":"Kwok","sequence":"additional","affiliation":[{"name":"Department of Medicine, Yan Chai Hospital, Hong Kong, Hong Kong SAR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8025-3595","authenticated-orcid":false,"given":"Sze-Kit","family":"Yuen","sequence":"additional","affiliation":[{"name":"Department of Medicine and Geriatrics, Caritas Medical Centre, Hong Kong, Hong Kong SAR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1816-4754","authenticated-orcid":false,"given":"Sing-Leung","family":"Lui","sequence":"additional","affiliation":[{"name":"Department of Medicine, Tung Wah Hospital, Hong Kong, Hong Kong SAR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2955-638X","authenticated-orcid":false,"given":"Samuel Ka-Shun","family":"Fung","sequence":"additional","affiliation":[{"name":"Department of Medicine and Geriatrics, Princess Margaret Hospital, Hong Kong, Hong Kong SAR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3136-0941","authenticated-orcid":false,"given":"Sunny","family":"Wong","sequence":"additional","affiliation":[{"name":"Department of Medicine and Geriatrics, United Christian Hospital, Hong Kong, Hong Kong SAR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4962-4132","authenticated-orcid":false,"given":"Winnie Chiu-Wing","family":"Chu","sequence":"additional","affiliation":[{"name":"Department of Imaging and Interventional Radiology, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7211-5400","authenticated-orcid":false,"given":"Albert Chee Meng","family":"Ong","sequence":"additional","affiliation":[{"name":"Kidney Genetics Group, Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3744-4767","authenticated-orcid":false,"given":"Olivier","family":"Devuyst","sequence":"additional","affiliation":[{"name":"Institute of Physiology, University of Zurich, Z\u00fcrich, Switzerland"},{"name":"Division of Nephrology, UCLouvain Medical School, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9879-8388","authenticated-orcid":false,"given":"Philip Kam-Tao","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Medicine and Therapeutics, Prince of Wales Hospital, Hong Kong, Hong Kong SAR"},{"name":"CUHK Carol and Richard Yu Peritoneal Dialysis Research Centre, Hong Kong, Hong Kong SAR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"On behalf of the CysticHK cohort collaborators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,2,12]]},"reference":[{"issue":"10","key":"B1-20260601","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1681\/ASN.2018050493","article-title":"Prevalence estimates of polycystic kidney and liver disease by population sequencing","volume":"29","author":"Lanktree","year":"2018","journal-title":"J Am Soc Nephrol."},{"issue":"5","key":"B2-20260601","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1053\/j.ajkd.2015.07.037","article-title":"Autosomal dominant polycystic kidney disease: core curriculum 2016","volume":"67","author":"Chebib","year":"2016","journal-title":"Am J Kidney Dis."},{"issue":"2S","key":"B3-20260601","first-page":"S1","article-title":"KDIGO 2025 clinical practice guideline for the evaluation, management, and treatment of autosomal dominant polycystic kidney disease (ADPKD)","volume":"107","year":"2025","journal-title":"Kidney Int."},{"issue":"25","key":"B4-20260601","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","article-title":"Tolvaptan in patients with autosomal dominant polycystic kidney disease","volume":"367","author":"Torres","year":"2012","journal-title":"N Engl J Med."},{"issue":"20","key":"B5-20260601","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1056\/NEJMoa1710030","article-title":"Tolvaptan in later-stage autosomal dominant polycystic kidney disease","volume":"377","author":"Torres","year":"2017","journal-title":"N Engl J Med."},{"issue":"1","key":"B6-20260601","doi-asserted-by":"crossref","first-page":"22257","DOI":"10.1038\/s41598-023-48638-9","article-title":"Real-life use of tolvaptan in ADPKD: a retrospective analysis of a large Canadian cohort","volume":"13","author":"Calvaruso","year":"2023","journal-title":"Sci Rep."},{"issue":"8","key":"B7-20260601","doi-asserted-by":"crossref","first-page":"740","DOI":"10.34067\/KID.0002262020","article-title":"Regional variance of the early use of tolvaptan for autosomal dominant polycystic kidney disease","volume":"1","author":"Inoue","year":"2020","journal-title":"Kidney360."},{"issue":"1","key":"B8-20260601","doi-asserted-by":"crossref","first-page":"EVIDoa2100021","DOI":"10.1056\/EVIDoa2100021","article-title":"Prescribed water intake in autosomal dominant polycystic kidney disease","volume":"1","author":"Rangan","year":"2022","journal-title":"NEJM Evid."},{"issue":"10","key":"B9-20260601","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1016\/j.ekir.2024.07.012","article-title":"Biomarkers of kidney disease progression in ADPKD","volume":"9","author":"Ghanem","year":"2024","journal-title":"Kidney Int Rep."},{"issue":"5","key":"B10-20260601","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1681\/ASN.2016040448","article-title":"Urine osmolality, response to tolvaptan, and outcome in autosomal dominant polycystic kidney disease: results from the TEMPO 3:4 trial","volume":"28","author":"Devuyst","year":"2017","journal-title":"J Am Soc Nephrol."},{"issue":"3","key":"B11-20260601","doi-asserted-by":"crossref","first-page":"100965","DOI":"10.1016\/j.xkme.2025.100965","article-title":"Spot versus 24-Hour urine osmolality measurement in autosomal dominant polycystic kidney disease: a diagnostic test study","volume":"7","author":"Akbari","year":"2025","journal-title":"Kidney Med."},{"issue":"3","key":"B12-20260601","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1159\/000382081","article-title":"Urine and plasma osmolality in patients with autosomal dominant polycystic kidney disease: reliable indicators of vasopressin activity and disease prognosis?","volume":"41","author":"Casteleijn","year":"2015","journal-title":"Am J Nephrol."},{"issue":"1","key":"B13-20260601","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1681\/ASN.2008050507","article-title":"Unified criteria for ultrasonographic diagnosis of ADPKD","volume":"20","author":"Pei","year":"2009","journal-title":"J Am Soc Nephrol."},{"issue":"suppl 4","key":"B14-20260601","doi-asserted-by":"crossref","first-page":"iv26","DOI":"10.1093\/ndt\/gfu091","article-title":"Building a network of ADPKD reference centres across Europe: the EuroCYST initiative","volume":"29","author":"Petzold","year":"2014","journal-title":"Nephrol Dial Transplant."},{"issue":"5","key":"B15-20260601","doi-asserted-by":"crossref","first-page":"715","DOI":"10.34067\/KID.0000000000000433","article-title":"Clinical characteristics and kidney outcomes in Chinese patients with autosomal dominant polycystic kidney disease","volume":"5","author":"Fung","year":"2024","journal-title":"Kidney360."},{"issue":"21","key":"B16-20260601","doi-asserted-by":"crossref","first-page":"6505","DOI":"10.3390\/jcm13216505","article-title":"Serum osmolality as a predictor of renal function decline: a retrospective cohort study","volume":"13","author":"Wu","year":"2024","journal-title":"J Clin Med."},{"issue":"1","key":"B17-20260601","doi-asserted-by":"crossref","first-page":"e0169137","DOI":"10.1371\/journal.pone.0169137","article-title":"Increased serum sodium and serum osmolarity are independent risk factors for developing chronic kidney disease; 5 year cohort study","volume":"12","author":"Kuwabara","year":"2017","journal-title":"PLoS One."},{"issue":"5808","key":"B18-20260601","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1136\/bmj.2.5808.282","article-title":"Antidiuretic and growth hormones","volume":"2","author":"Davies","year":"1972","journal-title":"Br Med J."},{"issue":"1","key":"B20-20260601","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/ki.2009.397","article-title":"Copeptin, a surrogate marker of vasopressin, is associated with microalbuminuria in a large population cohort","volume":"77","author":"Meijer","year":"2010","journal-title":"Kidney Int."},{"issue":"4","key":"B21-20260601","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/TP.0b013e3181b11ae4","article-title":"Copeptin, a surrogate marker of vasopressin, is associated with accelerated renal function decline in renal transplant recipients","volume":"88","author":"Meijer","year":"2009","journal-title":"Transplantation."},{"issue":"11","key":"B22-20260601","doi-asserted-by":"crossref","first-page":"4131","DOI":"10.1093\/ndt\/gfs070","article-title":"Copeptin, a surrogate marker for vasopressin, is associated with kidney function decline in subjects with autosomal dominant polycystic kidney disease","volume":"27","author":"Boertien","year":"2012","journal-title":"Nephrol Dial Transplant."},{"issue":"10","key":"B23-20260601","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/ki.2012.225","article-title":"Autosomal dominant polycystic kidney disease is associated with central and nephrogenic defects in osmoregulation","volume":"82","author":"Ho","year":"2012","journal-title":"Kidney Int."},{"issue":"2","key":"B24-20260601","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/ki.1989.38","article-title":"The clinical utility of renal concentrating capacity in polycystic kidney disease","volume":"35","author":"Gabow","year":"1989","journal-title":"Kidney Int."},{"issue":"4","key":"B25-20260601","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/MNH.0b013e3283621510","article-title":"Osmoregulation, vasopressin, and cAMP signaling in autosomal dominant polycystic kidney disease","volume":"22","author":"Devuyst","year":"2013","journal-title":"Curr Opin Nephrol Hypertens."},{"issue":"suppl 1","key":"B26-20260601","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000463063","article-title":"Polycystic kidney disease and the vasopressin pathway","volume":"70","author":"van Gastel","year":"2017","journal-title":"Ann Nutr Metab."},{"issue":"6","key":"B27-20260601","doi-asserted-by":"crossref","first-page":"906","DOI":"10.2215\/CJN.11311111","article-title":"Vasopressin, copeptin, and renal concentrating capacity in patients with autosomal dominant polycystic kidney disease without renal impairment","volume":"7","author":"Zittema","year":"2012","journal-title":"Clin J Am Soc Nephrol."}],"container-title":["Kidney360"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.34067\/KID.0000001126","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T19:57:46Z","timestamp":1786478266000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.34067\/KID.0000001126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,12]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.34067\/kid.0000001126","relation":{},"ISSN":["2641-7650"],"issn-type":[{"value":"2641-7650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,12]]},"assertion":[{"value":"2025-10-16","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-29","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}